Evidence map›Paper›PMID 37667759›Full record

ArticleIJU case reports2023

Adenocarcinoma in ectopic prostatic tissue at the trigone of urinary bladder.

Shunsuke Mori, Takahiro Maekawa, Yuma Kujime, Mai Akiyama, Makoto Matsushita, Mototaka Sato, Norihide Tei, Osamu Miyake

Open access · goldAbstract readCase Reports
In one paragraph

Article in IJU case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shunsuke MoriDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.ORCID https://orcid.org/0009-0007-5482-4397
Takahiro MaekawaDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.
Yuma KujimeDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.
Mai AkiyamaDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.
Makoto MatsushitaDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.
Mototaka SatoDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.ORCID https://orcid.org/0000-0001-5270-3021
Norihide TeiDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.
Osamu MiyakeDepartment of Urology Toyonaka Municipal Hospital Osaka Japan.
Toyonaka Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ectopic prostatic tissue is prostatic tissue located distant from the prostate gland. Although its existence is not uncommon, the occurrence of adenocarcinoma in ectopic prostatic tissue is rare. Case presentation: A 68-year-old man was suspected to have a nodular-type tumor in the bladder trigone and a tumor in the prostate based on magnetic resonance imaging and cystoscopy results. Transurethral tumor resection and transrectal prostate needle biopsy revealed the coexistence of ectopic prostatic adenocarcinoma in the bladder trigone and low-risk orthotopic prostate cancer. Four years later, the tumor evolved to intermediate-risk prostate cancer during active surveillance, and the patient underwent prostatectomy with resection of the bladder trigone. Pathology indicated no residual ectopic prostatic tissue or adenocarcinoma at the bladder trigone. Conclusion: Adenocarcinoma in ectopic prostatic tissue is very rare; however, when found, the possibility of concurrent cancer in the prostate gland should be considered.

Indexed as

adenocarcinomabladder metastasisdifferential diagnosisectopic prostatic tissueurinary bladder

Identifiers

PMID37667759
PMCPMC10475339
OpenAlexW4385278792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.